Novo Nordisk, Pfizer make personnel waves as they squabble over Metseranews2025-11-07T12:00:59+00:00November 7th, 2025|Endpoints News|
Onchilles raises $25M to take cancer-killing enzyme into human studiesnews2025-11-07T12:00:14+00:00November 7th, 2025|Endpoints News|
Eccogene targets $150M in HKEX listing for MASH, obesity drugsnews2025-11-07T11:30:06+00:00November 7th, 2025|Endpoints News|
Patient in Intellia CRISPR trial dies after being hospitalized with liver injurynews2025-11-07T02:34:55+00:00November 7th, 2025|Endpoints News|
Evommune CEO talks about sticking with $150M IPO plan during government shutdownnews2025-11-07T00:28:59+00:00November 7th, 2025|Endpoints News|
Zuckerberg-backed Biohub hires EvolutionaryScale team in apparent end of AI startupnews2025-11-07T00:06:20+00:00November 7th, 2025|Endpoints News|
#ASN25: Eledon plots path forward for kidney transplant drug despite Phase 2 missnews2025-11-06T23:30:09+00:00November 6th, 2025|Endpoints News|
Eisai plots label expansion for subcutaneous Leqembi, details early launch progressnews2025-11-06T20:26:42+00:00November 6th, 2025|Endpoints News|
FDA approves J&J’s Darzalex for smoldering multiple myelomanews2025-11-06T20:20:50+00:00November 6th, 2025|Endpoints News|
Makary pushes bounds of FDA commissioner role on prices, drug reviews and personnelnews2025-11-06T20:08:18+00:00November 6th, 2025|Endpoints News|
